Celltrion and LISCure Biosciences to develop unique microbiome treatment for Parkinson’s disease 1 min read News Celltrion and LISCure Biosciences to develop unique microbiome treatment for Parkinson’s disease Gauri Kurdukar February 23, 2023 LISCure Biosciences Inc., a clinical-stage biotech is developing advanced microbiome technology with accurate targets and announced a multi-year... Read More Read more about Celltrion and LISCure Biosciences to develop unique microbiome treatment for Parkinson’s disease
